Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01990079 · ClinicalTrials.gov registry record · NA
Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01990079: Completed NA study, sponsored by Duke University.
NCT01990079 is a NA study that has completed, run by Duke University. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01990079, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The primary goal of the study is to evaluate the use of a new smart phone application in preventing relapse to smoking among people with PTSD. The technology intervention will combine a mobile system to reward non-smoking, smoking cessation counseling, smoking cessation medications, and use of the smart phone app. The primary aim is to evaluate how effective this intervention is in preventing smoking relapse compared to another intervention that does not include the app.
Primary Outcome
Participants' self-report of smoking in the past seven days will be measured at the end of the treatment intervention, and at 3 and 6-month follow-up contacts.
Interventions
- DRUG Bupropion
- DRUG nicotine replacement therapy
- OTHER Smoking cessation counseling
- BEHAVIORAL mobile contingency management
- OTHER Stay Quit Coach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-08 |
| Phase | NA |
What the finished NCT01990079 record still lists
NCT01990079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Bupropion is the first listed.
NCT01990079 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01990079 about?
NCT01990079 is a clinical study titled "Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD". The primary goal of the study is to evaluate the use of a new smart phone application in preventing relapse to smoking among people with PTSD. The technology intervention will combine a mobile system to reward non-smoking, smoking cessation counseling, smoking cessation medications, and use of the s...
What is the current status of trial NCT01990079?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2013-12. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01990079?
The interventions under investigation include: Bupropion (DRUG), nicotine replacement therapy (DRUG), Smoking cessation counseling (OTHER), mobile contingency management (BEHAVIORAL), Stay Quit Coach (OTHER).
Who is sponsoring clinical trial NCT01990079?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01990079's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia